Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Who’s Next? Ten Potential Medtech Takeover Targets

Executive Summary

Device firms have already been active with M&A deals in 2014. Here are 10 companies to look for as potential acquisition targets going forward.

You may also be interested in...



Boston Sci Links With Guidewire Specialist In Pursuit Of 2015 FFR Launch

Boston Scientific signed an agreement with the Japanese guidewire-maker Asahi Intecc to develop a fractional flow reserve wire that Boston seeks to launch as part of its first FFR system next year. Asahi will also provide components to upgrade Boston’s RotaWire atherectomy guidewire.

Ankles Away: Stryker Raises Bet On Extremities With SBi Acquisition

Stryker is buying substantially all assets of Small Bone Innovations for up to $375 million, further increasing attention to the orthopedic extremities market, and, in particular, total ankle replacement.

Volcano Cuts Deeper Into Peripheral Market With AtheroMed Buy

Volcano will pay $115 million, plus a potential milestone, for AtheroMed and its Phoenix atherectomy system, as part of the firm’s growing emphasis on the peripheral artery device market.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT035815

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel